Arthur Kluge

Title: Arthur Kluge: Innovator in Pharmaceutical Chemistry

Introduction

Arthur Kluge is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work has the potential to impact cancer treatment significantly.

Latest Patents

Arthur Kluge holds a patent for "Salts of R-ketorolac." This patent includes solid salts, such as crystalline salts of the meglumine and tromethamine salts of R-ketorolac. The patent also discloses methods for preparing these salts, pharmaceutical compositions that comprise them, and methods for treating cancer using these salts. He has 1 patent to his name.

Career Highlights

Kluge is affiliated with the University of New Mexico, where he continues to engage in research and development in pharmaceutical sciences. His work is characterized by a commitment to advancing medical treatments through innovative chemical solutions.

Collaborations

Arthur Kluge has collaborated with notable colleagues, including Emily Rigsbee and Ekaterina Albert. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their field.

Conclusion

Arthur Kluge's contributions to pharmaceutical chemistry, particularly through his patent on R-ketorolac salts, highlight his role as an innovator in the medical field. His ongoing work at the University of New Mexico continues to pave the way for advancements in cancer treatment.